Literature DB >> 11744441

Progress in prostate cancer chemoprevention: modulators of promotion and progression.

R Lieberman1, C Bermejo, H Akaza, P Greenwald, W Fair, I Thompson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744441     DOI: 10.1016/s0090-4295(01)01416-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  7 in total

1.  Chemoprevention and prostate cancer.

Authors:  Masood A Khan; Alan W Partin
Journal:  Rev Urol       Date:  2003

Review 2.  Evolving strategies for prostate cancer chemoprevention trials.

Authors:  Ronald Lieberman
Journal:  World J Urol       Date:  2003-04-01       Impact factor: 4.226

3.  Chemopreventive potential of curcumin in prostate cancer.

Authors:  Marie-Hélène Teiten; François Gaascht; Serge Eifes; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2009-10-06       Impact factor: 5.523

Review 4.  Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer.

Authors:  Nurul Azwa Abd Wahab; Nordin H Lajis; Faridah Abas; Iekhsan Othman; Rakesh Naidu
Journal:  Nutrients       Date:  2020-03-02       Impact factor: 5.717

Review 5.  Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials.

Authors:  Maria G Grammatikopoulou; Konstantinos Gkiouras; Stefanos Τ Papageorgiou; Ioannis Myrogiannis; Ioannis Mykoniatis; Theodora Papamitsou; Dimitrios P Bogdanos; Dimitrios G Goulis
Journal:  Nutrients       Date:  2020-09-29       Impact factor: 5.717

6.  Chemoprevention of prostate cancer: soy isoflavones and curcumin.

Authors:  Shigeo Horie
Journal:  Korean J Urol       Date:  2012-10-19

7.  Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model.

Authors:  Emrah Yatkin; Lauri Polari; Teemu D Laajala; Annika Smeds; Christer Eckerman; Bjarne Holmbom; Niina M Saarinen; Tero Aittokallio; Sari I Mäkelä
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.